Why unreported clinical trial results pose a danger to modern medicine
In short: This video explores how the failure to publish negative or inconclusive drug trial results leaves the medical community in the dark, potentially leading to dangerous prescribing decisions.
Ben Goldacre examines the systemic issue of missing data in pharmaceutical research. When clinical trials for new drugs are conducted, the findings should be shared with the global medical community to ensure safety and efficacy.
However, a significant problem arises when negative or inconclusive results go unreported. This lack of transparency is not just a matter of incomplete records; it is a misleading and dangerous practice that prevents doctors and researchers from having a complete picture of a drug's true impact.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: What doctors don't know about the drugs they prescribe - Ben Goldacre
- Also: What doctors don't know about the drugs they prescribe
To cite this card, link to https://intellectplus.co.uk/app/ideas-what-doctors-don-t-know-about-the-drugs-they-prescribe-ben-g.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
